Chris Morrow talks about mycoplasma vaccination in layers
Published:January 18, 2021
Chris Morrow (Bioproperties) commented about the problems that arise from mycoplasma infections in layer farms and explained the benefits of a live mycoplasma vaccination program, including costs and profits.
The vaccine should not be expected to solve the mycoplasma problem if biosecurity measures are not implemented. Cultivation of various age categories in the industry is not possible and such will never give a satisfactorily healthy flock.